cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Senti Biosciences Inc
1 own
Current Price
$0
$0.02
(0.98%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
54.81M
52-Week High
52-Week High
10
52-Week Low
52-Week Low
1.2
Average Volume
Average Volume
0.04M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization54.81M
icon52-Week High10
icon52-Week Low1.2
iconAverage Volume0.04M
iconDividend Yield--
iconP/E Ratio--
What does the Senti Biosciences Inc do?
Dynamics Special Purpose Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2021 and is based in Redwood City, California.
Read More
News & Events about Senti Biosciences Inc.
Globe Newswire
7days ago
R&D focus is on lead oncology candidate SENTI-202 for the treatment of AML and other CD33 and/or FLT3 expressing hematologic malignancies, and SENTI-401 to target colorectal cancer and other CEA-positive solid tumors SENTI-202 on track for IND filing in 2H 2023 Cash runway guidance extended through ...
Globe Newswire
1month ago
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (Senti Bio), a biotechnology company innovating next-generation cell and gene therapies using its proprietary gene circuit platform, today announced that Tim Lu, MD, PhD, Co-founder and Chief ...
Globe Newswire
1month ago
ASH poster presentation summarizes preclinical data from SENTI-202, an off-the-shelf CAR-NK cell therapy candidate engineered with a logic-gated gene circuit and multi-armed with crIL-15, that is advancing toward clinical development for hematologic malignancies SENTI-202 is on track for IND filing ...
Globe Newswire
2 months ago
Review of new preclinical data and clinical development plan for SENTI-202 in hematologic malignancies; also featuring KOL discussion of treatment landscape and unmet need in AML Live and webcast event on Sunday, December 11, 11:30 am - 12:30 pm CST SOUTH SAN FRANCISCO, Calif., Nov. 23, 2022 (GLOBE ...
Globe Newswire
3 months ago
Poster presentation to highlight preclinical data for SENTI-202 which employs Logic Gating gene circuit technology in off-the-shelf CAR-NK cells designed to more precisely target CD33 and/or FLT3 expressing AML cell lines while protecting healthy cellsSOUTH SAN FRANCISCO, Calif., Nov. 03, 2022 (...
Frequently Asked Questions
Frequently Asked Questions
What is Senti Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Senti Biosciences Inc shares?
plus_minus_icon
How can I buy Senti Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Senti Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Senti Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Senti Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Senti Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Senti Biosciences Inc?
plus_minus_icon
What percentage is Senti Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Senti Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.02
(0.98%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00